American Portfolios Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$189 Hold
9
﹤0.01% 3461
2022
Q2
$279 Hold
9
﹤0.01% 3447
2022
Q1
$370 Hold
9
﹤0.01% 3498
2021
Q4
$391 Sell
9
-307
-97% -$13.9K ﹤0.01% 3436
2021
Q3
$15.8K Buy
316
+73
+30% +$4.42K ﹤0.01% 2378
2021
Q2
$15.3K Buy
243
+167
+220% +$10.7K ﹤0.01% 2328
2021
Q1
$7.06K Buy
76
+67
+744% +$6.86K ﹤0.01% 2539
2020
Q4
$806 Sell
9
-4,781
-100% -$439K ﹤0.01% 2863
2020
Q3
$495K Sell
4,790
-108
-2% -$11.6K 0.03% 493
2020
Q2
$387K Buy
4,898
+58
+1% +$4.32K 0.03% 524
2020
Q1
$280K Buy
+4,840
New +$279K 0.02% 543
2019
Q4
Sell
-138
Closed -$7.21K 2861
2019
Q3
$7.21K Hold
138
﹤0.01% 2054
2019
Q2
$6.67K Buy
138
+45
+48% +$2.16K ﹤0.01% 2059
2019
Q1
$4.7K Buy
93
+7
+8% +$413 ﹤0.01% 2117
2018
Q4
$5.1K Sell
86
-27
-24% -$1.74K ﹤0.01% 1870
2018
Q3
$7.44K Sell
113
-39
-26% -$2.28K ﹤0.01% 1848
2018
Q2
$7.67K Hold
152
﹤0.01% 1826
2018
Q1
$8K Hold
152
﹤0.01% 1713
2017
Q4
$7.06K Buy
+152
New +$6.4K ﹤0.01% 1691

Other funds holding EBS

American Portfolios Advisors's EBS Position: Q3 2022 in Review

American Portfolios Advisors held its Emergent Biosolutions (EBS) position steady in Q3 2022 at 9 shares worth $189. The position accounts for ﹤0.01% of the portfolio, ranked #3461.

American Portfolios Advisors first reported a position in EBS in Q4 2017 and has held it in 19 quarters since. The position peaked at $495K in Q3 2020. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • American Portfolios Advisors held 9 shares of Emergent Biosolutions worth $189 as of Q3 2022.
  • American Portfolios Advisors left its Emergent Biosolutions share count unchanged in Q3 2022.
  • Emergent Biosolutions made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3461 holding.
  • American Portfolios Advisors first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 19 quarters since.
  • American Portfolios Advisors's Emergent Biosolutions position peaked at $495K in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.